SCIPHARM SARL has a total of 95 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2010. It filed its patents most often in China, Republic of Korea and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SCIPHARM SÀRL, VALEANT PHARMACEUTICALS NORTH AMERICA and NEURODERM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 9 | |
#2 | Republic of Korea | 8 | |
#3 | Australia | 7 | |
#4 | Brazil | 7 | |
#5 | Canada | 7 | |
#6 | Israel | 7 | |
#7 | Chile | 5 | |
#8 | EAPO (Eurasian Patent Organization) | 5 | |
#9 | Singapore | 5 | |
#10 | WIPO (World Intellectual Property Organization) | 5 | |
#11 | South Africa | 4 | |
#12 | United States | 3 | |
#13 | Hungary | 2 | |
#14 | Japan | 2 | |
#15 | Montenegro | 2 | |
#16 | Mexico | 2 | |
#17 | Peru | 2 | |
#18 | Ukraine | 2 | |
#19 | Colombia | 1 | |
#20 | Dominican Republic | 1 | |
#21 | Ecuador | 1 | |
#22 | EPO (European Patent Office) | 1 | |
#23 | Guatemala | 1 | |
#24 | Honduras | 1 | |
#25 | Nicaragua | 1 | |
#26 | Philippines | 1 | |
#27 | Serbia | 1 | |
#28 | Slovenia | 1 | |
#29 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Freissmuth Michael | 51 |
#2 | Koenig Xaver | 24 |
#3 | Gloeckel Christina | 23 |
#4 | Zebedin-Brandl Eva-Maria | 21 |
#5 | Kirkup Michael P | 18 |
#6 | Jain Nareshkumar F | 17 |
#7 | Ghone Sanjeevani A | 17 |
#8 | Marella Michael A | 17 |
#9 | Kazemi Zahra | 16 |
#10 | Keuerleber Simon | 13 |
Publication | Filing date | Title |
---|---|---|
SG11201906321WA | Novel process for preparing water soluble forskolin | |
CA2973147A1 | Composition for the treatment of hepatic veno-occlusive disease | |
BR112017016077A2 | "composition and method for use in increasing the efficacy of hematopoietic stem cell grafting after transplantation" | |
AU2012215606A1 | Novel composition for the treatment of cystic fibrosis | |
WO2012107364A1 | Novel composition for the treatment of cystic fibrosis | |
EA033717B1 | Method of ex vivo pretreatment of haematopoetic stem cells and pharmaceutical composition for enhancing engraftment of haematopoetic stem cells | |
CA2770066A1 | Prostacyclin, analogue or derivative thereof for the treatment of cystic fibrosis |